Cover Image
Market Research Report
Product code 
1109462

Global Celiac Disease Drugs Market 2022-2026

Published: | TechNavio (Infiniti Research Ltd.) | 120 Pages | Delivery time: 1-2 business days

Price

Back to Top
Global Celiac Disease Drugs Market 2022-2026
Published: July 29, 2022
TechNavio (Infiniti Research Ltd.)
Content info: 120 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

Global Celiac Diseases Drugs Market 2022-2026

Technavio has been monitoring the celiac disease drugs market and it is poised to grow by $ 601.57 mn during 2022-2026, accelerating at a CAGR of 16.95% during the forecast period. Our report on the celiac disease drugs market provides a holistic analysis, of market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by higher consumption of gluten-containing food, increasing prevalence of celiac disease, and government initiatives.

The celiac disease drugs market analysis includes type segment and geographic landscape.

Technavio's celiac diseases drugs market is segmented as below:

By Type

  • The first line of treatment
  • The second line of treatment

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the inorganic growth strategies as one of the prime reasons driving the celiac diseases drugs market growth during the next few years. Also, a robust pipeline and rise in pharmaceutical expenditure will lead to sizable demand in the market.

Technavio presents a detailed picture of the market through study, synthesis, and summation of data from multiple sources by analyzing key parameters. Our report on the celiac diseases drugs market covers the following areas:

  • Celiac diseases drugs market sizing
  • Celiac diseases drugs market forecast
  • Celiac diseases drugs market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading celiac diseases drugs market vendors that include 9 Meters Biopharma Inc., Adaptive Biotechnologies Corp., Almirall SA, Amgen Inc., AMYRA Biotech AG, Avaxia Biologics Inc., BioLineRx Ltd., Bristol Myers Squibb Co., Calypso Biotech, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd, Immunogenics LLC, Johnson and Johnson, Precigen Inc., Sanofi, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Vactech Oy, Zedira GmbH, and Artielle Immunotherapeutics Inc. Also, the celiac disease drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market through study, synthesis, and summation of data from multiple sources by analyzing key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR45214

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Therapy

  • 5.1 Market segments
  • Exhibit 24: Chart on Therapy - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Therapy - Market share 2021-2026 (%)
  • 5.2 Comparison by Therapy
  • Exhibit 26: Chart on Comparison by Therapy
  • Exhibit 27: Data Table on Comparison by Therapy
  • 5.3 First line treatment - Market size and forecast 2021-2026
  • Exhibit 28: Chart on First line treatment - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on First line treatment - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on First line treatment - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on First line treatment - Year-over-year growth 2021-2026 (%)
  • 5.4 Second line treatment - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Second line treatment - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Second line treatment - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Second line treatment - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Second line treatment - Year-over-year growth 2021-2026 (%)
  • 5.5 Market opportunity by Therapy
  • Exhibit 36: Market opportunity by Therapy ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 40: Chart on Geographic comparison
  • Exhibit 41: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Canada - Market size and forecast 2021-2026
  • Exhibit 62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.9 Germany - Market size and forecast 2021-2026
  • Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.10 UK - Market size and forecast 2021-2026
  • Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.11 France - Market size and forecast 2021-2026
  • Exhibit 74: Chart on France - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on France - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on France - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on France - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 79: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 81: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 82: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 83: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 84: Matrix on vendor position and classification
  • 10.3 Amgen Inc.
  • Exhibit 85: Amgen Inc. - Overview
  • Exhibit 86: Amgen Inc. - Product / Service
  • Exhibit 87: Amgen Inc. - Key offerings
  • 10.4 AMYRA Biotech AG
  • Exhibit 88: AMYRA Biotech AG - Overview
  • Exhibit 89: AMYRA Biotech AG - Product / Service
  • Exhibit 90: AMYRA Biotech AG - Key offerings
  • 10.5 BioLineRx Ltd.
  • Exhibit 91: BioLineRx Ltd. - Overview
  • Exhibit 92: BioLineRx Ltd. - Product / Service
  • Exhibit 93: BioLineRx Ltd. - Key offerings
  • 10.6 Bristol Myers Squibb Co.
  • Exhibit 94: Bristol Myers Squibb Co. - Overview
  • Exhibit 95: Bristol Myers Squibb Co. - Product / Service
  • Exhibit 96: Bristol Myers Squibb Co. - Key offerings
  • 10.7 Calypso Biotech
  • Exhibit 97: Calypso Biotech - Overview
  • Exhibit 98: Calypso Biotech - Product / Service
  • Exhibit 99: Calypso Biotech - Key offerings
  • 10.8 GlaxoSmithKline Plc
  • Exhibit 100: GlaxoSmithKline Plc - Overview
  • Exhibit 101: GlaxoSmithKline Plc - Business segments
  • Exhibit 102: GlaxoSmithKline Plc - Key news
  • Exhibit 103: GlaxoSmithKline Plc - Key offerings
  • Exhibit 104: GlaxoSmithKline Plc - Segment focus
  • 10.9 Immunogenics LLC
  • Exhibit 105: Immunogenics LLC - Overview
  • Exhibit 106: Immunogenics LLC - Product / Service
  • Exhibit 107: Immunogenics LLC - Key offerings
  • 10.10 Johnson and Johnson
  • Exhibit 108: Johnson and Johnson - Overview
  • Exhibit 109: Johnson and Johnson - Business segments
  • Exhibit 110: Johnson and Johnson - Key news
  • Exhibit 111: Johnson and Johnson - Key offerings
  • Exhibit 112: Johnson and Johnson - Segment focus
  • 10.11 Sanofi
  • Exhibit 113: Sanofi - Overview
  • Exhibit 114: Sanofi - Business segments
  • Exhibit 115: Sanofi - Key news
  • Exhibit 116: Sanofi - Key offerings
  • Exhibit 117: Sanofi - Segment focus
  • 10.12 Takeda Pharmaceutical Co. Ltd.
  • Exhibit 118: Takeda Pharmaceutical Co. Ltd. - Overview
  • Exhibit 119: Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Exhibit 120: Takeda Pharmaceutical Co. Ltd. - Key news
  • Exhibit 121: Takeda Pharmaceutical Co. Ltd. - Key offerings

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 122: Inclusions checklist
  • Exhibit 123: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 124: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 125: Research methodology
  • Exhibit 126: Validation techniques employed for market sizing
  • Exhibit 127: Information sources
  • 11.5 List of abbreviations
  • Exhibit 128: List of abbreviations
    • health: Includes veterinary drugs (excluded from the scope of the report)

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between 2021 and 2026
  • Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Therapy - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Therapy - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Therapy
  • Exhibits27: Data Table on Comparison by Therapy
  • Exhibits28: Chart on First line treatment - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on First line treatment - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on First line treatment - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on First line treatment - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Second line treatment - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on Second line treatment - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on Second line treatment - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Second line treatment - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Market opportunity by Therapy ($ million)
  • Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits40: Chart on Geographic comparison
  • Exhibits41: Data Table on Geographic comparison
  • Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on France - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on France - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on France - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on France - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Market opportunity By Geographical Landscape ($ million)
  • Exhibits79: Impact of drivers and challenges in 2021 and 2026
  • Exhibits80: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits81: Overview on factors of disruption
  • Exhibits82: Impact of key risks on business
  • Exhibits83: Vendors covered
  • Exhibits84: Matrix on vendor position and classification
  • Exhibits85: Amgen Inc. - Overview
  • Exhibits86: Amgen Inc. - Product / Service
  • Exhibits87: Amgen Inc. - Key offerings
  • Exhibits88: AMYRA Biotech AG - Overview
  • Exhibits89: AMYRA Biotech AG - Product / Service
  • Exhibits90: AMYRA Biotech AG - Key offerings
  • Exhibits91: BioLineRx Ltd. - Overview
  • Exhibits92: BioLineRx Ltd. - Product / Service
  • Exhibits93: BioLineRx Ltd. - Key offerings
  • Exhibits94: Bristol Myers Squibb Co. - Overview
  • Exhibits95: Bristol Myers Squibb Co. - Product / Service
  • Exhibits96: Bristol Myers Squibb Co. - Key offerings
  • Exhibits97: Calypso Biotech - Overview
  • Exhibits98: Calypso Biotech - Product / Service
  • Exhibits99: Calypso Biotech - Key offerings
  • Exhibits100: GlaxoSmithKline Plc - Overview
  • Exhibits101: GlaxoSmithKline Plc - Business segments
  • Exhibits102: GlaxoSmithKline Plc - Key news
  • Exhibits103: GlaxoSmithKline Plc - Key offerings
  • Exhibits104: GlaxoSmithKline Plc - Segment focus
  • Exhibits105: Immunogenics LLC - Overview
  • Exhibits106: Immunogenics LLC - Product / Service
  • Exhibits107: Immunogenics LLC - Key offerings
  • Exhibits108: Johnson and Johnson - Overview
  • Exhibits109: Johnson and Johnson - Business segments
  • Exhibits110: Johnson and Johnson - Key news
  • Exhibits111: Johnson and Johnson - Key offerings
  • Exhibits112: Johnson and Johnson - Segment focus
  • Exhibits113: Sanofi - Overview
  • Exhibits114: Sanofi - Business segments
  • Exhibits115: Sanofi - Key news
  • Exhibits116: Sanofi - Key offerings
  • Exhibits117: Sanofi - Segment focus
  • Exhibits118: Takeda Pharmaceutical Co. Ltd. - Overview
  • Exhibits119: Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Exhibits120: Takeda Pharmaceutical Co. Ltd. - Key news
  • Exhibits121: Takeda Pharmaceutical Co. Ltd. - Key offerings
  • Exhibits122: Inclusions checklist
  • Exhibits123: Exclusions checklist
  • Exhibits124: Currency conversion rates for US$
  • Exhibits125: Research methodology
  • Exhibits126: Validation techniques employed for market sizing
  • Exhibits127: Information sources
  • Exhibits128: List of abbreviations